FDA Application Search and EMA Document Links

The integrated source on this page is openFDA Drugs@FDA. Search a product or ingredient name, or enter a prefixed application number such as an NDA or ANDA identifier. Results show up to ten matching applications with their product names, sponsor and dated submission history. Each application links to its official Drugs@FDA record, where available review documents, approval correspondence and labels can be inspected. This is application and product discovery; it is not a full-text search of every regulatory document.

Application identity matters because the same ingredient can appear in several products, strengths, dosage forms and sponsors. A familiar brand name alone does not establish that you have found the right record. Compare the application number with product numbers, dosage forms, routes and ingredient strengths shown in the result. The application may contain more than one product. Keep that relationship visible rather than treating an application-level fact as though it applies independently to every possible formulation.

The submission timeline is ordered by the source’s submission-status date. The timeline preserves the source type, number and status codes instead of turning every event into an approval claim. An original application and a later supplement are different events. Open the official application history to identify the document associated with the question you are answering and confirm how the status should be interpreted.

Each downloaded application result retains its identifier, source, jurisdiction, available dataset date and retrieval timestamp. Those values should remain attached when you create a comparison or regulatory-history table. A dataset update date describes the feed, while a submission date describes an event in one application. Neither is a substitute for checking the effective version of the label or the exact date on a review document.

For a US–EU comparison, organise evidence by product and jurisdiction, then record the document type, date and official link. Explain differences in the approved population, formulation or indication before comparing conclusions. Do not infer authorisation in one region from a decision in another. The same caution applies to clinical effectiveness and payer coverage: an application history does not answer every question about clinical value or reimbursement.

This page does not write a submission, determine regulatory strategy or certify compliance. It uses public application metadata and preserves official links. Documents can include applicant material or other third-party content with separate reuse terms. Follow the agency policies and retain attribution when quoting brief passages in research notes. Copy or download the current result set before leaving; signup does not move that evidence into the AnswerThis app automatically.

openFDA terms · EMA legal notice. Check the original publisher’s reuse terms for each portal document; an integrated-provider policy does not grant rights to other publishers’ content.